Bio-Sourcing
PrivateLast Round
Grant
Jan 12, 2026
Total Funding Raised
$22.17M
Company Overview
Bio-Sourcing operates in Healthcare & Life Sciences and is based in Liège. Its latest recorded funding round was an Accelerator round in September 2024.
Bio-Sourcing is a biotechnology company that develops a platform for producing biotherapeutics, such as monoclonal antibodies, in the milk of genetically engineered goats.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bio-Sourcing Comparables
Compare Bio-Sourcing with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LFB Group | 76% | |
| Baiya Phytopharm | 76% | |
| KBio Inc. | 74% |
For institutional investors. Book with your work email.
Bio-Sourcing Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 12, 2026 | ||||
| Accelerator | Sep 24, 2024 | ||||
| VC Round | Sep 24, 2024 | ||||
| Grant | May 28, 2024 | ||||
| Series A | Nov 7, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bio-Sourcing Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Public service of Wallonia | Grant |
| Luxembourg Développement | Series A |
| Noshaq | Series A |
| Investsud | Series A |
| Eurostars SME programme | Grant |
| Agipi Innovation | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Grew 20% QoQ, from 25 to 30 employees.
- Mar 20, 2026
Partnering with The Tiny Cargo Company on new antibody therapies.
For institutional investors. Book with your work email.
Bio-Sourcing Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bio-Sourcing's valuation, stock price, and market status.
Is Bio-Sourcing a public or private company?
Bio-Sourcing is a private company.
What is the current stock price of Bio-Sourcing?
Bio-Sourcing is a private company, so its shares have no public market price. Caplight tracks Bio-Sourcing's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bio-Sourcing worth (valuation)?
Valuation information for Bio-Sourcing is not publicly available.
Can I buy Bio-Sourcing stock?
Bio-Sourcing shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bio-Sourcing's last funding round?
Bio-Sourcing's most recent funding round was Grant on January 12, 2026.
Who are the main investors in Bio-Sourcing?
Key investors in Bio-Sourcing include European Innovation Council (EIC) Accelerator.
Will Bio-Sourcing IPO soon?
No public IPO plans have been announced for Bio-Sourcing.
How can I track Bio-Sourcing secondary market activity?
Caplight tracks bids, offers, and trades in Bio-Sourcing's shares on secondary markets.